Navigation Links
Simbionix Signs an Agreement with the Laparoscopic Surgical Skills Foundation (LSS)
Date:2/20/2013

CLEVELAND, Ohio, February 20, 2013 /PRNewswire/ --

Simbionix and the Laparoscopic Surgical Skills Foundation (LSS) signed a collaboration agreement that is supported by Europe's most prestigious society in the laparoscopic discipline, The European Association for Endoscopic Surgery (EAES).  Training materials and assessment tools for the European Laparoscopic Skills Curriculum will be the result of this initiative.

     (Logo: http://photos.prnewswire.com/prnh/20120502/529202-a)
Recent safety and surgical quality performance reports from the World Health Organization and others stress the urgent need for the improvement of training, assessment, and accreditation for technology-dependent surgical procedures such as laparoscopy. LSS is an initiative by the European Association for Endoscopic Surgery (EAES) to provide a standard to (re)credential surgeons to perform laparoscopic surgery effectively and safely. LSS goes beyond the basic skills and focuses on safeguarding the quality of performance in laparoscopic procedures.

This agreement is a continuation of successful two-year collaboration during which the LSS program has been operating in training centers across Europe.  This incorporates the Simbionix LAP Mentor in the process of defining and validating the criterion-based assessment tool and clinical assessment of index procedures performance.

Professor Jakimowicz, MD, PhD, FRCS Ed said, "This agreement shows the benefit of industry and professional society collaboration. The structure of the training, applicability of the course content in practice and the proportion of theory and hands-on training are rated positively by the trainees."  Prof. Jakimowicz added, "The LSS program appeals to both residents in training and already accredited surgeons. International participation indicates that the LSS program has the po
'/>"/>

SOURCE Simbionix Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
2. MicroConstants China Signs Site Management Organization Agreement with the Clinical Research Center of No. 307 Hospital
3. SafeCode Drug Technologies Corp Signs an Agreement With INTOVISION PRODUCT DEVELOPMENT & DESIGN (An Israeli Product Development Co) to Manufacturers the Worlds First Voice Recognition Drug Safety Application Prototype
4. Joint Reconstruction (Hip and Knee Devices) Market to 2018 - Advanced Implant Materials, Innovative Designs and Improved Longevity lead to Rise in the Number of Early Joint Replacement Surgeries
5. UV Flu Technologies Signs a Distribution Agreement with DPG Distribution
6. Volcano Corporation Signs Agreement to Acquire Sync-Rx Ltd.
7. Reckitt Benckiser Signs Merger Agreement To Acquire Schiff Nutrition
8. Colorado Telehealth Network Signs Contract with GNAX Health to Provide Statewide Medical Image Archive and Exchange
9. Medisafe 1 Technologies Signs the $7MM Perpetual License Agreement
10. TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
11. HealthTrust Purchasing Group Signs Renewal for GHX Solutions to Continue Supply Chain Cost Reductions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 02, 2015 Research and ... of the "The Future of Pharmaceutical Outsourcing" ... they are in a desperate need to develop ... cost, drug companies have been increasingly utilizing external ... productivity while constantly streamlining their internal operation. Their ...
(Date:6/3/2015)... SHANGHAI , June 3, 2015 MEDTEC China South ... an extension of MEDTEC China 2015, MEDTEC China South has ... attributes, standing out as a key event for the medical ... After many years of challenges, this year marks the successful return ... 10 years after the event first debuted there in 2005. ...
(Date:6/3/2015)... , June 3, 2015 Genoa ... Pharmaceuticals, Inc., bringing together two pharmacy organizations with proven ... illness. Both companies have strong reputations for outstanding customer ... Genoa is the ... health community and those affiliated with managing the cost ...
Breaking Medicine Technology:The Future of Pharmaceutical Outsourcing: 2015 Report 2MEDTEC Successfully Returns to Southern China 2MEDTEC Successfully Returns to Southern China 3Genoa, a QoL Healthcare Company Acquires Northeast Pharmaceuticals, Inc. 2
... , MORRISTOWN, N.J. , March 11 ... today announced the U.S. Food and Drug Administration (FDA) ... suspension), a new twice-yearly formulation of TRELSTAR®, a proven, ... With an anticipated May launch, TRELSTAR® 22.5 mg is ...
... , THOUSAND OAKS, Calif. , March 11 ... has received a US Patent Office Notice of Allowance ... expressing, secreting, and purifying the NELL-1 sequence of the ... a Chinese hamster ovary (CHO) cell. This patent continues ...
Cached Medicine Technology:FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 2FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 3FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 4FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 5FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 6FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 7FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 8Bone Biologics Announces Another Major US Patent Issuance for Recombinant Protein Process 2Bone Biologics Announces Another Major US Patent Issuance for Recombinant Protein Process 3
(Date:6/3/2015)... 03, 2015 blingsting announces their new ... car's glove compartment or can be strapped onto a ... features a pointed tip that will allow the user ... blade that can cut through a seatbelt or carseat ... Glammer include:, ,         Easily break a window ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 EMBARGOED FOR RELEASE ... Birth Weight Associated with Proximity of Mother’s Home to Gas ... close to a high density of natural gas wells drilled ... lower birth weights than women living farther from such wells, ... Public Health analysis of southwestern Pennsylvania birth records. ...
(Date:6/3/2015)... The Canton Group, a leading web ... announced today that Tim Dodge has joined the company ... The Canton Group as it implements an ambitious ... , Tim is a tech industry veteran who has ... technology companies. Before joining The Canton Group, Tim was ...
(Date:6/3/2015)... June 03, 2015 On the heels of ... billion industry by 2020 ( click here to review ... scientists believe Baltimore has the talent to become ... which genetic code and other biological data are collected and ... “Baltimore contains all the elements of a perfect storm ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Alberto Grignolo, ... at DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award ... level of excellence, and commitment to service on a ... Global Connector Award that annually recognizes one DIA member ... advanced the mission of DIA to foster innovation to ...
Breaking Medicine News(10 mins):Health News:blingsting Announces All New Car Safety Tool The Glammer 2Health News:Fracking Proximity Associated with Lower Birth Weight 2Health News:Fracking Proximity Associated with Lower Birth Weight 3Health News:Fracking Proximity Associated with Lower Birth Weight 4Health News:The Canton Group Appoints Tim Dodge as Chief Marketing Officer 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3
... variety of therapeutic categories can be screened to identify effective ... for publication in the Endocrine Society,s Journal of Clinical ... rapidly be implemented into a clinical trial to test how ... chemical agents capable of modulating a disease is a long ...
... trial found that rilonacept, an inhibitor of the ... that occur when initiating uric acid-lowering therapy. Results ... targeted therapy in prevention of gout flaresshow rilonacept ... infections or treatment-related serious adverse events reported. Full ...
... WEDNESDAY, Jan. 4 (HealthDay News) -- Nearly one in four ... that her risk of getting other sexually transmitted diseases is ... commonly transmitted sexually transmitted infection (STI) in the United States, ... to 19 infected. Some virus types can raise the ...
... women against infection from one of the two types of herpes ... New England Journal of Medicine . The vaccine was ... did not protect women from herpes simplex virus type 2 (HSV-2). ... herpes caused by HSV-1 58 percent fewer -- in women ...
... By Mary Brophy Marcus HealthDay Reporter , ... against the hepatitis C virus, which can cause severe liver ... it,s likely years away, researchers are reporting. , , There ... estimated 170 million people worldwide. , , Like HIV, the ...
... (HealthDay News) -- New research shows that women with ... from depression and so-called "disordered eating," regardless of whether ... that most [study] participants frequently adhered to a gluten-free ... to increased vitality, lower stress, decreased depressive symptoms and ...
Cached Medicine News:Health News:New drug screening identifies chemical agents with potent anti-cancer activity 2Health News:Clinical trial demonstrates that rilonacept significantly reduces gout flares 2Health News:Clinical trial demonstrates that rilonacept significantly reduces gout flares 3Health News:Many Teen Girls Mistakenly Think HPV Vaccines Cut Risk for All STDs 2Health News:Many Teen Girls Mistakenly Think HPV Vaccines Cut Risk for All STDs 3Health News:Research shows progress toward a genital herpes vaccine 2Health News:Research shows progress toward a genital herpes vaccine 3Health News:Novel Hepatitis C Vaccine Shows Some Early Promise 2Health News:Novel Hepatitis C Vaccine Shows Some Early Promise 3Health News:Celiac Disease in Women Linked to Depression Risk 2
... The Hoffmann® II Compact™ Upper extremity fixator ... of the distal radius by allowing independent ... One of the main goals has been ... providing total versatility and ease of use. ...
The Small External Fixator has straight or angled frames, independent pin placement, and combines easily with Large and Medium External Fixator frames....
... Fixator is now available in a convenient, ... instrumentation. The surgical technique is printed on ... , ,This fixator allows the surgeon to ... multipaner adjustments in the frame via joints ...
... Fixation System for distal radius fractures allows ... length and rotation. The unique wrist lock ... into extension without losing fracture reduction. Post-op ... the surgeons office. Priced competitively and sold ...
Medicine Products: